Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Merck & Co., Inc.

Capitalization 29TCr 25TCr 23TCr 22TCr 39TCr 26,43800Cr 41TCr 2,69700Cr 1,06900Cr 12,63100Cr 1,07300Cr 1,05000Cr 45,62000Cr P/E ratio 2026 *
27x
P/E ratio 2027 * 13.3x
Enterprise value 32TCr 28TCr 25TCr 24TCr 43TCr 29,24400Cr 45TCr 2,98300Cr 1,18200Cr 13,97100Cr 1,18600Cr 1,16100Cr 50,46200Cr EV / Sales 2026 *
4.74x
EV / Sales 2027 * 4.32x
Free-Float
70.67%
Yield 2026 *
2.92%
Yield 2027 * 3.01%
1 day-0.26%
1 week-0.16%
Current month-6.63%
1 month-4.78%
3 months+15.26%
6 months+39.61%
Current year+9.83%
1 week 114.11
Extreme 114.11
119
1 month 113.82
Extreme 113.82
125.14
Current year 104.43
Extreme 104.43
125.14
1 year 73.31
Extreme 73.31
125.14
3 years 73.31
Extreme 73.31
134.63
5 years 70.89
Extreme 70.89
134.63
10 years 51.33
Extreme 51.33
134.63
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2021
Director of Finance/CFO 57 01/04/2021
Chief Tech/Sci/R&D Officer 57 01/08/2020
Director TitleAgeSince
Director/Board Member 65 27/11/2007
Director/Board Member 73 01/09/1995
Chairman 59 01/12/2022
Change 5d. change 1-year change 3-years change Capi.($)
-0.26%-0.16%+22.07%+9.34% 29TCr
+0.80%-0.53%+22.88%+203.58% 88TCr
-0.21%+0.47%+48.18%+57.79% 58TCr
-2.52%-4.53%+3.84%+44.57% 39TCr
+0.79%-6.01%+5.81%+21.36% 32TCr
+0.11%-0.83%+21.02%+34.57% 30TCr
+0.43%-1.54%+25.20%+62.42% 29TCr
-0.43%-0.90%+17.13%+57.05% 20TCr
+0.42%+0.74%+27.91%+82.35% 18TCr
+0.02%-0.34%-52.94%-49.79% 17TCr
Average -0.26%-1.36%+14.11%+52.33% 35.94TCr
Weighted average by Cap. -0.36%-1.32%+19.74%+79.55%

Financials

2026 *2027 *
Net sales 6.67TCr 5.83TCr 5.27TCr 5.04TCr 9.17TCr 6,17000Cr 9.53TCr 63TCr 25TCr 2,94800Cr 25TCr 25TCr 10,64700Cr 7.04TCr 6.16TCr 5.56TCr 5.32TCr 9.68TCr 6,51500Cr 10TCr 66TCr 26TCr 3,11200Cr 26TCr 26TCr 11,24200Cr
Net income 1.02TCr 892.22Cr 806.07Cr 771.1Cr 1.4TCr 94TCr 1.46TCr 9.63TCr 3.82TCr 45TCr 3.83TCr 3.75TCr 1,62900Cr 2.11TCr 1.85TCr 1.67TCr 1.6TCr 2.9TCr 1,95500Cr 3.02TCr 20TCr 7.9TCr 93TCr 7.93TCr 7.77TCr 3,37400Cr
Net Debt 3.03TCr 2.65TCr 2.4TCr 2.29TCr 4.17TCr 2,80600Cr 4.33TCr 29TCr 11TCr 1,34100Cr 11TCr 11TCr 4,84200Cr 1.84TCr 1.61TCr 1.45TCr 1.39TCr 2.53TCr 1,70100Cr 2.63TCr 17TCr 6.88TCr 81TCr 6.9TCr 6.76TCr 2,93500Cr
Logo Merck & Co., Inc.
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.4%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (20%); - sale of animal health products (9.2%); - other (1.4%). Net sales are distributed geographically as follows: the United States (50.3%), Europe/Middle East/Africa (21.8%), Latin America (5.4%), China (8.6%), Japan (5.1%), Asia/Pacific (4.8%) and other (4%).
Employees
74,000
Date Price Change Volume
13/26/13 115.61 $ -0.26% 71,11,035
12/26/12 115.91 $ -0.26% 83,49,180
11/26/11 116.21 $ -0.75% 67,69,631
10/26/10 117.09 $ -0.02% 97,39,257
09/26/09 117.11 $ +1.14% 83,21,571
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
115.61USD
Average target price
127.78USD
Spread / Average Target
+10.52%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW